Created with Sketch.
At the Intersection of Science and Law
32 minutes | Oct 5, 2021
Understanding AI and its use in drug discovery
DLA Piper partners Ellen Scordino and Susan Krumplitsch are joined by Duane Valz, General Counsel of Insitro, to discuss how machine learning is being used to generate and leverage data for the development of better medicines.
26 minutes | Sep 3, 2021
mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando
For decades, scientists have studied the seemingly endless possibilities of custom-made messenger RNA, or mRNA. Kathy Fernando, Head Vice President, Worldwide of Clinical Operations at Pfizer, spent her early bench science career working with mRNA technology and had a front row seat to the creation of the COVID-19 vaccine. In this episode, DLA Piper’s Dr. Lisa Haile talks with Dr. Fernando about the study of mRNA and how COVID-19 catalyzed its advancement.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2021